Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

Some people have a genetic variation that makes them less effective at breaking down drugs.

Agaricus bisporus derived β-Glucan could be an effective cervical cancer treatment with antimicrobial and antioxidant properties.

Low-level laser therapy helps increase hair growth in female pattern hair loss but not in telogen effluvium.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Early treatment of acne is crucial to prevent scarring and psychological effects.

675 nm laser therapy effectively improves hair growth and density in AGA patients.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

The conference reported improvements in muscle volume, skin cancer diagnosis, facial and vaginal rejuvenation, and hair growth using various laser treatments.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Photobiomodulation helps reduce pain, lessen inflammation, heal wounds, and can be used in skin treatments. It also boosts hair growth in women with hair loss and may help fight microbes and prevent respiratory issues in COVID-19.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Cosmeceuticals may benefit skin health but need more research for efficacy and safety confirmation.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

675 nm laser therapy effectively improves hair growth in Indian patients with androgenetic alopecia.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.